This multidisciplinary expert panel opinion on bacteriophage therapy has been written in the context of a society that is confronted with an everincreasing number of antibiotic resistant bacteria. To avoid the return to a pre-antibiotic era, alternative treatments are urgently needed. The authors aim to contribute to the opinion formation of relevant stakeholders on how to potentially develop an infrastructure and legislation that paves the way for the acceptance and re-implementation of bacteriophage therapy.
Bibliographical note© 2016 The Authors. Biotechnology Journal published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Alavidze, Z., Aminov, R., Betts, A., Bardiau, M., Bretaudeau, L., Caplin, J., Nino, C., Coffey, A., Cooper, I., & De Vos, D. (2016). Silk route to the acceptance and re-implementation of bacteriophage therapy - Expert round table on acceptance and re-implementation of bacteriophage therapy. Biotechnology Journal, 11(5), 595-600. https://doi.org/10.1002/biot.201600023